NEWS
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
Mainz Biomed will present its largest colorectal cancer screening study to date at the ASCO 2024 Annual Meeting. The study, combining data from ColoFuture and eAArly DETECT studies, includes 690 subjects across 30 clinical sites. The novel screening test, which uses mRNA biomarkers, FIT tests, and an AI algorithm, showed a 92.3% sensitivity for colorectal cancer and 82.3% for advanced precancerous lesions. This innovative, non-invasive approach aims to enhance early detection of colorectal cancer and advanced adenomas, potentially reducing cancer mortality rates globally. The presentation session will be held on June 1, 2024, from 13:30 to 16:30 CDT.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1106Followers
70Following
7686Visitors
Follow